Non-Small Cell Lung Cancer Market Size, Trends Analysis, 2032

• Chapter 1. Preface
  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology
• Chapter 2. Executive Summary
  • 2.1. Non-Small Cell Lung Cancer Market, 2024 - 2032, (USD Billion)
  • 2.2. Non-Small Cell Lung Cancer Market: Snapshot
• Chapter 3. Global Non-Small Cell Lung Cancer Market - Industry Analysis
  • 3.1. Non-Small Cell Lung Cancer Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. Wider availability of Treatment
  • 3.3. Restraints
    • 3.3.1. High Cost
  • 3.4. Opportunity
    • 3.4.1. Exploring new disease types
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market attractiveness analysis by Type Segment
    • 3.6.2. Market attractiveness analysis by Therapy Segment
    • 3.6.3. Market attractiveness analysis by Distribution Channel segment
    • 3.6.4. Market attractiveness analysis by regional segment
• Chapter 4. Global Non-Small Cell Lung Cancer Market - Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Non-Small Cell Lung Cancer market: company market share analysis, 2024
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New therapy launches
    • 4.2.3. Agreements, partnerships, collaborations and joint ventures
    • 4.2.4. Research and development and regional expansion
• Chapter 5. Global Non-Small Cell Lung Cancer Market - Type Segment Analysis
  • 5.1. Global Non-Small Cell Lung Cancer market overview: by Type
    • 5.1.1. Global Non-Small Cell Lung Cancer market revenue share, by Type, 2024 and 2032
  • 5.2. Squamous cell (epidermoid) carcinoma
    • 5.2.1. Global Non-Small Cell Lung Cancer market by Squamous cell (epidermoid) carcinoma, 2024-2032 (USD Billion)
  • 5.3. Adenocarcinoma
    • 5.3.1. Global Non-Small Cell Lung Cancer market by Adenocarcinoma, 2024-2032 (USD Billion)
  • 5.4. Large cell (undifferentiated) carcinoma
    • 5.4.1. Global Non-Small Cell Lung Cancer market by Large cell (undifferentiated) carcinoma, 2024-2032 (USD Billion)
  • 5.5. Other
    • 5.5.1. Global Non-Small Cell Lung Cancer market by Other, 2024-2032 (USD Billion)
• Chapter 6. Global Non-Small Cell Lung Cancer Market - Therapy Segment Analysis
  • 6.1. Global Non-Small Cell Lung Cancer market overview: by Therapy
    • 6.1.1. Global Non-Small Cell Lung Cancer market revenue share, by Therapy, 2024 and 2032
  • 6.2. Chemotherapy
    • 6.2.1. Global Non-Small Cell Lung Cancer market by Chemotherapy, 2024-2032 (USD Billion)
  • 6.3. Radiotherapy
    • 6.3.1. Global Non-Small Cell Lung Cancer market by Radiotherapy, 2024-2032 (USD Billion)
  • 6.4. Laser therapy
    • 6.4.1. Global Non-Small Cell Lung Cancer market by Laser therapy, 2024-2032 (USD Billion)
  • 6.5. Photodynamic therapy (PDT)
    • 6.5.1. Global Non-Small Cell Lung Cancer market by Photodynamic therapy (PDT), 2024-2032 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global Non-Small Cell Lung Cancer market by Others, 2024-2032 (USD Billion)
• Chapter 7. Global Non-Small Cell Lung Cancer Market - Distribution Channel Segment Analysis
  • 7.1. Global Non-Small Cell Lung Cancer market overview: by Distribution Channel
    • 7.1.1. Global Non-Small Cell Lung Cancer market revenue share, by Distribution Channel, 2024 and 2032
  • 7.2. Hospital pharmacies
    • 7.2.1. Global Non-Small Cell Lung Cancer market by Hospital pharmacies, 2024-2032 (USD Billion)
  • 7.3. Online pharmacies
    • 7.3.1. Global Non-Small Cell Lung Cancer market by Online pharmacies, 2024-2032 (USD Billion)
  • 7.4. Others
    • 7.4.1. Global Non-Small Cell Lung Cancer market by Others, 2024-2032 (USD Billion)
• Chapter 8. Global Non-Small Cell Lung Cancer Market - Regional Analysis
  • 8.1. Global Non-Small Cell Lung Cancer market overview: by region
    • 8.1.1. Global Non-Small Cell Lung Cancer market revenue share, by region, 2024 and 2032
  • 8.2. North America
    • 8.2.1. North America Non-Small Cell Lung Cancer market, by country, 2024-2032 (USD Billion)
    • 8.2.2. North America Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
    • 8.2.3. North America Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
    • 8.2.4. North America Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
    • 8.2.5. The U.S.
      • 8.2.5.1. U.S. Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
      • 8.2.5.2. U.S. Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
      • 8.2.5.3. The U.S. Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
    • 8.2.6. Rest of North America
      • 8.2.6.1. Rest of North America Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
      • 8.2.6.2. Rest of North America Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
      • 8.2.6.3. Rest of North America Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
  • 8.3. Europe
    • 8.3.1. Europe Non-Small Cell Lung Cancer market, by country, 2024-2032 (USD Billion)
    • 8.3.2. Europe Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
    • 8.3.3. Europe Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
    • 8.3.4. Europe Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
    • 8.3.5. UK
      • 8.3.5.1. UK Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
      • 8.3.5.2. UK Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
      • 8.3.5.3. UK Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
    • 8.3.6. France
      • 8.3.6.1. France Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
      • 8.3.6.2. France Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
      • 8.3.6.3. France Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
    • 8.3.7. Germany
      • 8.3.7.1. Germany Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
      • 8.3.7.2. Germany Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
      • 8.3.7.3. Germany Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
    • 8.3.8. Rest of Europe
      • 8.3.8.1. Rest of Europe Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
      • 8.3.8.2. Rest of Europe Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
      • 8.3.8.3. Rest of Europe Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Non-Small Cell Lung Cancer market, by country, 2024-2032 (USD Billion)
    • 8.4.2. Asia Pacific Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
    • 8.4.3. Asia Pacific Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
    • 8.4.4. Asia Pacific Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
    • 8.4.5. China
      • 8.4.5.1. China Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
      • 8.4.5.2. China Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
      • 8.4.5.3. China Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
    • 8.4.6. France
      • 8.4.6.1. Japan Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
      • 8.4.6.2. Japan Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
      • 8.4.6.3. Japan Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
    • 8.4.7. India
      • 8.4.7.1. India Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
      • 8.4.7.2. India Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
      • 8.4.7.3. India Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
    • 8.4.8. Rest of Asia Pacific
      • 8.4.8.1. Rest of Asia Pacific Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
      • 8.4.8.2. Rest of Asia Pacific Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
      • 8.4.8.3. Rest of Asia Pacific Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
  • 8.5. Latin America
    • 8.5.1. Latin America Non-Small Cell Lung Cancer market, by country, 2024-2032 (USD Billion)
    • 8.5.2. Latin America Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
    • 8.5.3. Latin America Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
    • 8.5.4. Latin America Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
    • 8.5.5. Brazil
      • 8.5.5.1. Brazil Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
      • 8.5.5.2. Brazil Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
      • 8.5.5.3. Brazil Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
    • 8.5.6. Rest of Latin America
      • 8.5.6.1. Rest of Latin America Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
      • 8.5.6.2. Rest of Latin America Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
      • 8.5.6.3. Rest of Latin America Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
  • 8.6. Middle East & Africa
    • 8.6.1. Middle East and Africa Non-Small Cell Lung Cancer market, by country, 2024-2032 (USD Billion)
    • 8.6.2. Middle East and Africa Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
    • 8.6.3. Middle East and Africa Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
    • 8.6.4. Middle East and Africa Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion) 
• Chapter 10. Company Profiles
  • 10.1. Agennix AG
    • 10.1.1. Overview
    • 10.1.2. Financials
    • 10.1.3. Therapy Portfolio
    • 10.1.4. Business Strategy
    • 10.1.5. Recent Developments
  • 10.2. AstraZeneca
    • 10.2.1. Overview
    • 10.2.2. Financials
    • 10.2.3. Therapy Portfolio
    • 10.2.4. Business Strategy
    • 10.2.5. Recent Developments
  • 10.3. Eli Lily
    • 10.3.1. Overview
    • 10.3.2. Financials
    • 10.3.3. Therapy Portfolio
    • 10.3.4. Business Strategy
    • 10.3.5. Recent Developments
  • 10.4. GlaxoSmithKline
    • 10.4.1. Overview
    • 10.4.2. Financials
    • 10.4.3. Therapy Portfolio
    • 10.4.4. Business Strategy
    • 10.4.5. Recent Developments
  • 10.5. Merck & Co.
    • 10.5.1. Overview
    • 10.5.2. Financials
    • 10.5.3. Therapy Portfolio
    • 10.5.4. Business Strategy
    • 10.5.5. Recent Developments
  • 10.6. Novartis AG
    • 10.6.1. Overview
    • 10.6.2. Financials
    • 10.6.3. Therapy Portfolio
    • 10.6.4. Business Strategy
    • 10.6.5. Recent Developments
  • 10.7. Pfizer
    • 10.7.1. Overview
    • 10.7.2. Financials
    • 10.7.3. Therapy Portfolio
    • 10.7.4. Business Strategy
    • 10.7.5. Recent Developments
  • 10.8. Roche
    • 10.8.1. Overview
    • 10.8.2. Financials
    • 10.8.3. Therapy Portfolio
    • 10.8.4. Business Strategy
    • 10.8.5. Recent Developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Non-Small Cell Lung Cancer market, 2024-2032 (USD Billion)
4. Porter’s five forces analysis: Non-Small Cell Lung Cancer market
5. Global Non-Small Cell Lung Cancer market attractiveness, by Type
6. Global Non-Small Cell Lung Cancer market attractiveness, by Therapy
7. Global Non-Small Cell Lung Cancer market attractiveness, by Distribution Channel
8. Global Non-Small Cell Lung Cancer market revenue share, by Type, 2024 and 2032
9. Global Non-Small Cell Lung Cancer market revenue share, by Therapy, 2024 and 2032
10. Global Non-Small Cell Lung Cancer market revenue share, by Distribution Channel, 2024 and 2032
11. Global Non-Small Cell Lung Cancer market revenue share, by region, 2024 & 2032
12. North America Non-Small Cell Lung Cancer market, 2024-2032 (USD Billion)
13. Europe Non-Small Cell Lung Cancer market, 2024-2032 (USD Billion)
14. Asia Pacific Non-Small Cell Lung Cancer market, 2024-2032 (USD Billion)
15. Latin America Non-Small Cell Lung Cancer market, 2024-2032 (USD Billion)
16. Middle East & Africa Non-Small Cell Lung Cancer market, 2024-2032 (USD Billion)

Table Of Tables

List of Tables

1. Global Non-Small Cell Lung Cancer market: snapshot
2. Drivers for Non-Small Cell Lung Cancer market: impact analysis
3. Restraints for Non-Small Cell Lung Cancer market: impact analysis
4. North America Non-Small Cell Lung Cancer market revenue, by country, 2024-2032 (USD Billion)
5. North America Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
6. North America Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
7. North America Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
8. U.S. Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
9. U.S. Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
10. U.S. Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
11. Rest of North America Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
12. Rest of North America Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
13. Rest of North America Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
14. Europe Non-Small Cell Lung Cancer market revenue, by country, 2024-2032 (USD Billion)
15. Europe Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
16. Europe Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
17. Europe Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
18. UK Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
19. UK Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
20. UK Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
21. Germany Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
22. Germany Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
23. Germany Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
24. France Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
25. France Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
26. France Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
27. Rest of Europe Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
28. Rest of Europe Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
29. Rest of Europe Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
30. Asia Pacific Non-Small Cell Lung Cancer market revenue, by country, 2024-2032 (USD Billion)
31. Asia Pacific Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
32. Asia Pacific Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
33. Asia Pacific Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
34. China Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
35. China Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
36. China Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
37. Japan Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
38. Japan Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
39. Japan Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
40. India Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
41. India Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
42. India Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
43. Rest of Asia Pacific Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
44. Rest of Asia Pacific Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
45. Rest of Asia Pacific Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
46. Latin America Non-Small Cell Lung Cancer market revenue, by country, 2024-2032 (USD Billion)
47. Latin America Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
48. Latin America Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
49. Latin America Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
50. Brazil Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
51. Brazil Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
52. Brazil Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
53. Rest of Latin America Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
54. Rest of Latin America Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
55. Rest of Latin America Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)
56. Middle East and Africa Non-Small Cell Lung Cancer market revenue, by country, 2024-2032 (USD Billion)
57. Middle East and Africa Non-Small Cell Lung Cancer market revenue, by Type, 2024-2032 (USD Billion)
58. Middle East and Africa Non-Small Cell Lung Cancer market revenue, by Therapy, 2024-2032 (USD Billion)
59. Middle East and Africa Non-Small Cell Lung Cancer market revenue, by Distribution Channel, 2024-2032 (USD Billion)